CHRNA7 and early-onset autosomal dominant Alzheimer disease: Recently, the α7 nicotinic acetylcholine receptor was reported to be associated with a range of neural diseases, including Alzheimer’s disease, schizophrenia, anxiety, depression and inflammation [25].